Kohler, S; Tschopp, O; Sze, L; Neidert, M C; Bernays, R L; Spanaus, K S; Wiesli, P; Schmid, C (2013). Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values? General and Comparative Endocrinology, 188:282-287.
Mutschler, J; Graf, N; Spanaus, K S; Rössler, W; Hergan, K; Binkert, C A; Gutzeit, A (2012). Circulating ghrelin levels are not associated with craving and withdrawal symptoms in acute nicotine withdrawal. Psychiatria Danubina, 24(2):229-230.
Serra, A L; Poster, D; Kistler, A D; Krauer, F; Raina, S; Young, J; Rentsch, K M; Spanaus, K S; Senn, O; Kristanto, P; Scheffel, H; Weishaupt, D; Wüthrich, R P (2010). Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. New England Journal of Medicine, 363(9):820-829.
Wyss, C A; Neidhart, M; Altwegg, L; Spanaus, K S; Yonekawa, K; Wischnewsky, M B; Corti, R; Kucher, N; Roffi, M; Eberli, F R; Amann-Vesti, B; Gay, S; von Eckardstein, Arnold; Lüscher, T F; Maier, W (2010). Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. European Heart Journal, 31(12):1457-1469.
Spanaus, K S; Kollerits, B; Ritz, E; Hersberger, M; Kronenberg, F; von Eckardstein, Arnold (2010). Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clinical Chemistry, 56(5):740-749.